| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2817954cd008bcd609a4c4eb49050be |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-143333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2004-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84935b63dfde400b8e8a79dd4663914e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7cbc1bf7e2e6b8d3d3cdee59c4d60a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f512acbf35d450e1fa7befe51bbc1beb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94013f3b5caa84caf1b5d92f4965663d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9584425f90d92b47b307ee393dfcd41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5a2d2eb656c559c64d85bd0f219230f |
| publicationDate |
2010-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1687443-B1 |
| titleOfInvention |
Fkbp51: a novel target for antidepressant therapy |
| abstract |
The present invention relates to a method of classifying an individual comprising analyzing the nucleic acid of a sample taken from said patient for nucleotide polymorphisms in a haplotype block comprising the gene encoding FKBP51 and/or determining the expression level of FKBP51 in said sample. In a preferred embodiment, the invention provides a method of predicting the response to CC. Furthermore, a method of developing an antidepressant drug, and pharmaceutical compositions are provided. |
| priorityDate |
2003-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |